Pharmacies qualifying for MHA’s specialty pharmacy program:
· Dispense high cost self-administered, infused and oral medications to patients undergoing intensive therapies for chronic and complex illnesses.
· Dedicate trained personnel to providing personal patient compliance and symptom monitoring
· Comply with requirements for specialized delivery and administration of related drugs
· Service a wide geographic area and are licensed in all states it services
· Provides payers, manufacturers and physicians with compliance, cost and service reports
Target diseases: Crohn’s, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Osteoporosis, Growth Insufficiency, Multiple Schlerosis, Hepatitis, Transplant
MHA is the largest GPO for Specialty Pharmacies:
· Fastest growing alternate site GPO servicing Specialty Pharmacies
· Provides contracts for key specialty drugs
· Dedicated field and support resources to assist members in attaining lowest COG’s possible
· Development of state-of-the-art, web-based technology for data collection tools driving compliance, market share penetration and rebate optimization
GPO of Choice for Manufacturers in Specialty Pharmacy—assisting manufacturers with market share and new drug launch goals through:
· Resources to support clinical education and compliance programs
· Information tools aggregating dispensing data to monitor market share and patient compliance
· Unique contracting approach supporting manufacturer’s market share and pricing strategies
· Assisting manufacturers with pre-approval market research and information
 |
|
|
|
 |
 |
|
 |
|
 |
|
 |
|